The urinary tract cancer global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Urinary Tract Cancer Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The urinary tract cancer market size has grown exponentially in recent years. It will grow from $2.65 billion in 2023 to $3.21 billion in 2024 at a compound annual growth rate (CAGR) of 21.1%. The growth in the historic period can be attributed to advancements in diagnostics, pharmaceutical developments, awareness and early detection, precision medicine.
The urinary tract cancer market size is expected to see rapid growth in the next few years. It will grow to $6.49 billion in 2028 at a compound annual growth rate (CAGR) of 19.3%. The growth in the forecast period can be attributed to immunotherapy advancements, telemedicine and remote monitoring, biomarker research, adjuvant therapies. Major trends in the forecast period include global collaboration, advances in palliative care, comprehensive survivorship programs, patient-centric care.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/urinary-tract-cancer-global-market-report
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Market Drivers –
The growing prevalence of bladder cancer is expected to propel the growth of the urinary tract cancer market. Bladder cancer refers to the development of cancerous cells within the tissues of the urinary bladder, which is a hollow organ in the pelvis responsible for storing urine produced by the kidneys until it is excreted from the body. This higher prevalence leads to greater demand for diagnostic tools, screening methods and treatment options for urinary tract cancer patients. For instance, in January 2023, according to the report published by the American Cancer Society Inc., a US-based voluntary organization for cancer awareness, the estimated cases of urinary system cancer increased to 168,560 in 2023, an increase of 2.66% from 164,190 in 2022 in the United States. Moreover, bladder cancer cases increased to 83,730 in 2021, an increase of 2.8% from 81,400 in 2020. Therefore, the growing prevalence of bladder cancer will drive the growth of the urinary tract cancer market.
Market Trends –
Major companies operating in the urinary tract cancer market are increasing their focus on advancement in treatment process to provide more effective and tailored solutions to gain a competitive edge in the market. Such advances in urinary tract cancer treatment emphasize precise interventions, leveraging the body’s immune system, improving surgical techniques and customizing treatments to suit the unique needs of individual patients. For instance, in October 2022, UC San Diego Health, a US-based healthcare system, introduced an advanced treatment for patients suffering from low-grade upper tract urothelial cancer (LG-UTUC), a relatively uncommon subtype of urinary system cancer. This advanced treatment provides an alternative approach to the traditional method of complete kidney removal, potentially sparing patients from the need for future dialysis or kidney transplants. The innovative therapy involves the administration of a drug named Jelmyto through a series of injections that contain mitomycin, a well-known chemotherapy agent, combined with a sterile hydrogel. The administration of this drug occurs through guided injections, which enable precise targeting of the tumor location within the urinary system.
The urinary tract cancer market covered in this report is segmented –
1) By Cancer Type: Bladder Cancer; Urethral Cancer; Ureteric And Renal Pelvic Cancer
2) By Treatment: Chemotherapy; Intravesical Therapy; Radiation Therapy; Surgery
3) By Diagnostic Techniques: Cystoscopy; Transurethral Resection Of The Tumor; Imaging Tests; Urine Analyses; Other Diagnostic Techniques
4) By Distribution Channel: Retail Pharmacy; Online Pharmacy
Get an inside scoop of the urinary tract cancer market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=13059&type=smp
Regional Insights –
North America was the largest region in the urinary tract cancer market in 2023. The regions covered in urinary tract cancer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Key Companies –
Major players in the urinary tract cancer market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck KGaA, Bayer AG, Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline PLC (GSK), Eli Lilly and Company, Amgen Inc., Astellas Pharma Inc., Eisai Co. Ltd., Boehringer Ingelheim GmbH, Incyte Corporation, Shionogi & Co. Ltd., Kyowa Hakko Kirin Co. Ltd., Endo International PLC, Seagen Inc., Exelixis Inc., Ferring Pharmaceuticals, Bavarian Nordic, EUSA Pharma, UroGen Pharma Inc., Mersana Therapeutics, Protara Therapeutics Inc., Spectrum Pharmaceuticals, IDL Biotech AB, AroCell AB, ImmunityBio Inc.
Table of Contents
1. Executive Summary
2. Urinary Tract Cancer Market Report Structure
3. Urinary Tract Cancer Market Trends And Strategies
4. Urinary Tract Cancer Market – Macro Economic Scenario
5. Urinary Tract Cancer Market Size And Growth
…..
27. Urinary Tract Cancer Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
